23.10.2012 • News • Recipharm • pharmaceutical industry • collaborations

Recipharm, Astimex to Collaborate on Development and Manufacturing

Recipharm and Astimex Pharma have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product.

The formulation development work will take place at the Recipharm Pharmaceutical Development site located in Solna close to Stockholm. Astimex Pharma also has the opportunity to choose Recipharm as the future manufacturer for the product.

Additionally, Astimex is in discussions with Recipharm for engagement to carry out other manufacturing and development contractual projects.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.